Search - tctmd.com

Displaying 361 - 380 of 455

Sort: Relevancy | Date

Presentation TVT 2013

Optimal Transseptal Technique for LAA Occlusion

Presenter: Brian Whisenant

June 15, 2013

Presentation TVT 2013

Mixed Marriage: TAVR and LAA Occlusion

Presenter: Sameer Gafoor

June 15, 2013

Presentation TVT 2013

LAA Closure for the Anticoagulation Intolerant Patient: Data and Common Sense

Presenter: Matthew Price

June 15, 2013

Presentation TVT 2013

Integrating TEE and Fluoroscopy for LAA Therapies

Presenter: Brian Whisenant

June 15, 2013

Presentation TVT 2013

Emerging Therapies for LAA Occlusion: The New Devices

Presenter: Jason Rogers

June 15, 2013

Presentation TVT 2013

CT Imaging of the LAA: Necessary for All or Device Specific?

Presenter: John Carroll

June 15, 2013

Presentation TVT 2013

Complication of LAA Closure: Lariat (SentreHEART)

Presenter: Matthew Price

June 15, 2013

Presentation TVT 2013

Complex LAA Anatomy (Watchman Closure): Chicken Wing Morphology

Presenter: Steven Yakubov

June 15, 2013

Presentation TVT 2013

Basic Echo Imaging of the LAA with Fluoroscopic Correlation

Presenter: Saibal Kar

June 15, 2013

Presentation TVT 2013

Transcatheter Closure of Incomplete Left Atrial Appendage Occlsuion (Previous Watchman LAA Occluder) - Implantation of a 2nd Generation ACP (Amulet) Device

Presenter: Simon Cheung Chi Lam

June 14, 2013

Presentation TVT 2013

Ad-hoc TAVI, Ad-hoc Coronary Stenting, and Ad-hoc LAA Closure

Presenter: Fabian Nietlispach

June 13, 2013

Presentation TCT Russia 2013

LAA Closure Devices - Technique Description and Emerging Data

Presenter: Horst Sievert

June 09, 2013

News Daily News

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

Yael L. Maxwell

June 07, 2013

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

Presentation

An Economic Evaluation of Percutaneous LAA Occlusion

Presenter: Sheldon M. Singh

June 04, 2013

Presentation

Percutaneous LAA Closure with the Amplatzer Cardiac Plug in Patients with Nonvalvular A-fib and Contraindications for Anticoagulation Therapy

Presenter: M. Urena

May 28, 2013

News Daily News

Cardiac Plug Shows High Success, Low Complication Rate for LAA Closure

L.A. McKeown

May 28, 2013

News Daily News

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Yael L. Maxwell

May 17, 2013

News Industry News

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

May 17, 2013

Presentation

PROTECT AF: The Mortality Effects of LAA Closure vs. Warfarin for Stroke Prophylaxis in A-fib

Presenter: Vivek Y. Reddy

May 14, 2013

Advertisement

Optimal Transseptal Technique for LAA Occlusion

Mixed Marriage: TAVR and LAA Occlusion

LAA Closure for the Anticoagulation Intolerant Patient: Data and Common Sense

Integrating TEE and Fluoroscopy for LAA Therapies

Emerging Therapies for LAA Occlusion: The New Devices

CT Imaging of the LAA: Necessary for All or Device Specific?

Complication of LAA Closure: Lariat (SentreHEART)

Complex LAA Anatomy (Watchman Closure): Chicken Wing Morphology

Basic Echo Imaging of the LAA with Fluoroscopic Correlation

Transcatheter Closure of Incomplete Left Atrial Appendage Occlsuion (Previous Watchman LAA Occluder) - Implantation of a 2nd Generation ACP (Amulet) Device

Ad-hoc TAVI, Ad-hoc Coronary Stenting, and Ad-hoc LAA Closure

LAA Closure Devices - Technique Description and Emerging Data

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

An Economic Evaluation of Percutaneous LAA Occlusion

Percutaneous LAA Closure with the Amplatzer Cardiac Plug in Patients with Nonvalvular A-fib and Contraindications for Anticoagulation Therapy

Cardiac Plug Shows High Success, Low Complication Rate for LAA Closure

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

PROTECT AF: The Mortality Effects of LAA Closure vs. Warfarin for Stroke Prophylaxis in A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content